The Global Burden of Glaucoma: Findings from the Global Burden of Disease 2019 Study and Predictions by Bayesian Age–Period–Cohort Analysis
暂无分享,去创建一个
Xiaomin Zhu | Lin Xie | Qianyi Lin | Yuanqing Cai | Wangdu Luo | Bingcai Jiang | Min Tang | Xiangji Li | Yi Lin
[1] Guangming Jin,et al. Disease Burden of Glaucoma in China: Findings from the Global Burden of Disease 2019 Study , 2022, Clinical epidemiology.
[2] N. Congdon,et al. Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017 , 2022, BMJ Open.
[3] T. Vos,et al. The hidden burden of eating disorders: an extension of estimates from the Global Burden of Disease Study 2019 , 2021, The lancet. Psychiatry.
[4] J. Stein,et al. Glaucoma in Adults-Screening, Diagnosis, and Management: A Review. , 2021, JAMA.
[5] Zhebin Du,et al. Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study , 2020, Biomarker Research.
[6] Jiayue Zhou,et al. Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016 , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.
[7] Min Fan,et al. Time trends and heterogeneity in the disease burden of glaucoma, 1990-2017: a global analysis , 2019, Journal of global health.
[8] Wenyong Huang,et al. Epidemiological variations and trends in health burden of glaucoma worldwide , 2019, Acta ophthalmologica.
[9] S. Ehl,et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data , 2018, Orphanet Journal of Rare Diseases.
[10] Brian C. Stagg,et al. A Worldwide Price Comparison of Glaucoma Medications, Laser Trabeculoplasty, and Trabeculectomy Surgery , 2018, JAMA ophthalmology.
[11] I. Rudan,et al. National and subnational prevalence and burden of glaucoma in China: A systematic analysis , 2017, Journal of global health.
[12] R. Ritch,et al. Glaucoma , 2017, The Lancet.
[13] Dan J Stein,et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[14] Leonhard Held,et al. Projecting the future burden of cancer: Bayesian age–period–cohort analysis with integrated nested Laplace approximations , 2017, Biometrical journal. Biometrische Zeitschrift.
[15] Nobhojit Roy,et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition , 2015, The Lancet.
[16] T. Wong,et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. , 2014, Ophthalmology.
[17] H. Taylor,et al. Prevalence and causes of vision loss in East Asia: 1990–2010 , 2014, British Journal of Ophthalmology.
[18] Paul P. Lee,et al. An assessment of the health and economic burdens of glaucoma. , 2011, American journal of ophthalmology.